Disease-modifying therapeutics through transformational science

FL60 is identifying novel therapeutic strategies targeted to responder patient populations for various complex diseases. Powered by the latest advancements in computational and experimental biology, we are evolving the medical paradigm for complex disease. FL60 was founded by Flagship Pioneering in Flagship Labs, the firm's innovation foundry, and is located in the heart of Cambridge, Mass.